Rxcurve
HCPCS J0289 · per 10 MG

Amphotericin b liposome inj

Products billed under this code include Ambisome, Amphotericin B Liposome.

Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J0289

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Ambisome Astellas Pharma US, Inc. 00469-3051-30 5 $89.255
Amphotericin B Liposome Heritage Pharmaceuticals Inc. 23155-0594-31 5 $89.255
Amphotericin B Liposome Eugia US LLC 55150-0365-01 5 $89.255
Amphotericin B Liposome Sun Pharmaceutical Industries, Inc. 62756-0233-01 5 $89.255
Amphotericin B Liposome Mylan Institutional LLC 67457-0926-50 5 $89.255

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $17.851 −$1.994 10 MG Amphotericin b liposome inj v1, posted September 17, 2026
3Q26 $19.845 −$2.962 10 MG Amphotericin b liposome inj v1, posted September 15, 2026
2Q26 $22.807 +$2.086 10 MG Amphotericin b liposome inj v1, posted September 15, 2026
1Q26 $20.721 −$0.762 10 MG Amphotericin b liposome inj v1, posted September 15, 2026
4Q25 $21.483 −$1.133 10 MG Amphotericin b liposome inj v1, posted September 8, 2026
3Q25 $22.616 −$0.691 10 MG Amphotericin b liposome inj v1, posted March 10, 2026
2Q25 $23.307 −$0.668 10 MG Amphotericin b liposome inj v1, posted March 10, 2026
1Q25 $23.975 +$0.65 10 MG Amphotericin b liposome inj v1, posted December 19, 2025
4Q24 $23.325 +$1.694 10 MG Amphotericin b liposome inj v1, posted June 11, 2025
3Q24 $21.631 −$6.051 10 MG Amphotericin b liposome inj v1, posted June 11, 2025
2Q24 $27.682 +$1.024 10 MG Amphotericin b liposome inj v1, posted March 11, 2025
1Q24 $26.658 −$1.265 10 MG Amphotericin b liposome inj v1, posted December 19, 2024
4Q23 $27.923 +$0.052 10 MG Amphotericin b liposome inj v1, posted October 10, 2024
3Q23 $27.871 +$1.02 10 MG Amphotericin b liposome inj v1, posted June 5, 2024
2Q23 $26.851 +$2.331 10 MG Amphotericin b liposome inj v1, posted February 23, 2024
1Q23 $24.52 −$1.384 10 MG Amphotericin b liposome inj v1, posted December 6, 2023
4Q22 $25.904 −$0.459 10 MG Amphotericin b liposome inj v1, posted June 22, 2023
3Q22 $26.363 −$1.015 10 MG Amphotericin b liposome inj v1, posted June 9, 2023
2Q22 $27.378 −$2.089 10 MG Amphotericin b liposome inj v1, posted December 14, 2022
1Q22 $29.467 +$0.72 10 MG Amphotericin b liposome inj v1, posted June 8, 2022
4Q21 $28.747 +$0.413 10 MG Amphotericin b liposome inj v1, posted June 2, 2022
3Q21 $28.334 +$1.267 10 MG Amphotericin b liposome inj v1, posted June 2, 2022
2Q21 $27.067 −$0.172 10 MG Amphotericin b liposome inj v1, posted March 1, 2022
1Q21 $27.239 – 10 MG Amphotericin b liposome inj v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files